Cargando…
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
BACKGROUND: tumor recurrence after NSCLC surgical resection is the most common cause of treatment failure that sharply reduces the patient’s life expectancy. The optimal treatment strategy for loco-regional recurrences developing after surgical resection in patients with non–small-cell lung cancer (...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288672/ https://www.ncbi.nlm.nih.gov/pubmed/35842660 http://dx.doi.org/10.1186/s13014-022-02084-5 |